Synthesis and Solid State Pharmaceutical Centre (SSPC) team members, Kristy Butler, Louise O’Neill, Jon O’Halloran, General Manager and Aisling Arthur
Monday, October 9, 2017

Synthesis and Solid State Pharmaceutical Centre (SSPC), a Science Foundation Ireland (SFI) funded research centre was recently named Pharma Research Centre of the Year at the Pharma Industry Awards 2017 for the third consecutive year.

Hosted at the Bernal Institute, University of Limerick, the national research centre was presented with the award for its outstanding national and international industry-academia, inter-industry, and inter-academia collaborations.

SSPC offers many benefits to industry partners from research activities, including the development of scientific and technological advances, a shift in emphasis for the Irish sites within their corporations, and advanced education and training of company employees.

The centre was also shortlisted in the top four nominees for Pharma Industry Company of the Year and Partnership Alliance of the Year.

Speaking after the event, Jon O’Halloran, SSPC General Manager, commented: “"We are delighted to have won this award, as it is a great chance to celebrate the unique partnerships within the SSPC.

“It is a great honour that we, a national research centre, have been recognised for our continued commitment to this type of collaboration, particularly one that closely engages with industry partners. To win this category for the third time successively is a great honour,” Mr O’Halloran added.

Since launching in 2014, the Pharma Industry Awards has established itself as the benchmark for excellence for those operating in Ireland's pharma industry.

For the fourth year SSPC have been fortunate to win and this year marks the third consecutive year being awarded Pharma Research Centre of the Year.

The SSPC transcends company and academic boundaries and is the largest research collaboration in Ireland, and one of the largest globally, within the pharmaceutical area.

The role of the SSPC is to link experienced scientists and engineers in academia and the pharmaceutical industry, to address critical research challenges.